Patty P. Bloom, M.D.

Patricia (Patty) Pringle Bloom, M.D., is a transplant hepatologist in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, Minnesota. Dr. Bloom provides comprehensive care for adults with the full spectrum of liver disease, from abnormal liver tests and chronic liver conditions to cirrhosis and liver transplantation.

She has particular expertise in caring for patients with advanced liver disease and complications such as hepatic encephalopathy and ascites.

Dr. Bloom is also an NIH-funded clinical and translational researcher whose work seeks to improve how complications of cirrhosis are detected, prevented and treated. Her research focuses particularly on hepatic encephalopathy and the gut-liver-brain connection, including the roles of the intestinal microbiome and intestinal permeability.

She also studies innovative diagnostic approaches, such as speech analysis and digital health tools, and evaluates new therapies through patient-centered clinical trials. Her goal is to translate scientific discoveries into practical strategies that improve patients' function, quality of life, and long-term outcomes.

Dr. Bloom is board certified in internal medicine, gastroenterology and transplant hepatology.

Areas of expertise

Dr. Bloom provides specialized care for individuals with advanced liver disease and related complications.

• Transplant hepatology: Evaluation and management of patients before and after liver transplantation
• Advanced liver disease: Comprehensive care for cirrhosis and its complications
• Hepatic encephalopathy: Diagnosis and treatment strategies for cognitive changes related to liver disease
• Portal hypertension: Management of complications such as variceal bleeding and ascites
• Autoimmune and metabolic liver disorders: Care for conditions including autoimmune hepatitis and related syndromes

Research and expertise

Dr. Bloom's research focuses on improving outcomes for people with liver disease through innovative therapies, microbiome-targeted approaches, and digital health solutions. She has served as principal investigator on national studies funded by the NIH and foundations, examining microbiome-based therapeutics and predictive tools for hepatic encephalopathy. Dr. Bloom has published widely, lectures internationally and actively mentors future leaders in gastroenterology and hepatology.

She is board-certified by the American Board of Internal Medicine in internal medicine, gastroenterology and transplant hepatology.